Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2019 08:30 ET | Source: Organogenesis Holdings Inc.

Latest Wound Care Research from Organogenesis Highlighted at SAWC Spring 2019

CANTON, Mass. and SAN ANTONIO, April 30, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and...
April 02, 2019 07:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2019 Financial Results on May 10, 2019

CANTON, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
April 01, 2019 08:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Compliant With Nasdaq Listing Criteria

CANTON, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the “Company”) (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and...
March 18, 2019 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results

CANTON, Mass. , March 18, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
March 12, 2019 09:00 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Announces ReNu® Clinical Trial Results at AAOS 2019 Annual Meeting

CANTON, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
March 11, 2019 07:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Present at Oppenheimer’s 29th Annual Healthcare Conference

CANTON, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
March 04, 2019 09:00 ET | Source: Organogenesis Holdings Inc.

New Study Shows PuraPly® Antimicrobial Positively Impacts Course of Healing Across Variety of Wound Types

CANTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
February 25, 2019 08:00 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 18, 2019

CANTON, Mass., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
January 24, 2019 10:00 ET | Source: Organogenesis Holdings Inc.

Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz

CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...